PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1712019-1	1991	To determine the epitopic structure for an anti-GalNAc alpha-Ser(Thr) (anti-Tn) monoclonal antibody, MLS 128, asialo-ovine submaxillary mucin was digested with various proteases, and the digests were fractionated by immunoaffinity column chromatography and high performance liquid chromatography.	Threonine	65-68	LOC100508689	Homo sapiens	136-141	
1712019-4	1991	On treatment with V8 protease, GP-I was converted to two glycopeptides, one with poor reactivity and the other with intermediate reactivity.	Glycopeptides	57-70	glucose-6-phosphate isomerase	Homo sapiens	31-35	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Leucine	57-60	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Serine	61-64	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Glutamic Acid	66-69	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Serine	70-73	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Threonine	75-78	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Threonine	80-83	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Glutamine	85-88	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Leucine	89-92	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Proline	93-96	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Glycine	97-100	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-6	1991	GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached.	Acetylgalactosamine	149-161	glucose-6-phosphate isomerase	Homo sapiens	0-4	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	85-91	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Serine	130-133	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Threonine	142-145	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Serine	154-157	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Serine	154-157	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Threonine	183-186	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	N-acetylgalactosaminuronic acid	123-129	GTP binding protein 1	Homo sapiens	19-25	
1712019-8	1991	The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GalNAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)-Ser, and GalNAc-Thr-(GalNAc)-Thr.	Threonine	183-186	GTP binding protein 1	Homo sapiens	19-25